Burden of Gastric Cancer : A Case Study of Iran

Abstract

Introduction: Cancers have come to be one of the most significant causes of mortality in human societies today. Gastric cancer is more likely to cause more disease and more costs to the patient and the health system of the community. The present study was aimed to evaluate the burden of gastric cancer in Iran, Kohgiluyeh & Boyerahmad province in 2015. Methods: The present descriptive cross-sectional study was conducted in Kohgiluyeh & Boyer-Ahmad Province of Iran in 2015. All 110 patients diagnosed with gastric cancer were studied. The patients' characteristics had been recorded in the Iran Cancer Registry System and records of patients with gastric cancer in the Health Department of Yasuj University of Medical Sciences. The required data was collected using a researcher-made data collection form and were analyzed using Excel 2013 software, assuming a zero discount rate and a steady-state weight of the patients' age. Results: The results indicated that the number of disability adjusted life years (DALYs) in the province was 754.03 years (1.06 per 1000 people), which was higher in men (1.44 per 1000) and in the age group of 60-69 years (8.29 per 1000). Conclusion: Considering the significant extent of valuable life years lost due to premature death or disability resulting from gastric cancer in the province, and the severe damage to both the family and the community, paying attention to adopting preventive policies, social and financial support for patients to prepare medicines and accommodation and establishing specialized medical centers in the cities are necessary.

Economic Burden of Gastric Cancer: A Case of Iran

“…10 The results of a study showed that the burden of gastric cancer and the number of disability-adjusted life-years in the province of Kohgiluyeh and Boyer Ahmad in 2015 was 754.03 years, indicating a high burden of disease. 11 On the other hand, cancer, especially gastric cancer, in addition to their high burden of disease which leads to a reduction in production and productivity in the economy, imposes heavy costs on households and the health system. These costs are also very important from the societal perspective and account for 5% to 10% of the total health-care costs in most developed countries.…”

Detection of R282w P53 Gene Mutation on Exon 8 in Gastric Cancer Patients in Southwest Iran

“…Although the incidence of GC is gradually decreasing in many regions of Iran, but it is still the most common malignancy in K&B province (6). Based on the official statistics of the Ministry of Health (2015) the number of patients with GC registered in the K&B province has been increasing (25). However, no study is performed at the molecular level to identify the mutation rate of effective genes in GC, such as the R282W P53 mutation in the patients and healthy populations in K&B province.…”